Seattle, WA, United States of America

John Hohmann

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 9.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • La Conner, WA (US) (2015)
  • Seattle, WA (US) (2014 - 2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: John Hohmann: Innovator in Neurological Treatments

Introduction

John Hohmann is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of medical research, particularly in the development of treatments for neurological disorders. With a total of 4 patents, Hohmann's work has the potential to impact the lives of many individuals suffering from various conditions.

Latest Patents

Hohmann's latest patents include groundbreaking inventions such as "G protein coupled receptor 85 and SREB3 knockout mice and uses thereof." This invention provides GPCR polypeptides and polynucleotides, recombinant materials, and transgenic mice, along with methods for their production. These polypeptides and polynucleotides are useful in diagnosing and treating diseases and disorders. Additionally, the invention offers methods for identifying compounds, such as agonists or antagonists, that can treat conditions associated with GPCR dysfunction. Another significant patent is related to the "Use of PDE7 inhibitors for the treatment of movement disorders." This method addresses movement abnormalities linked to neurological disorders, including Parkinson's disease and Restless Leg Syndrome, by administering a therapeutically effective amount of a PDE7 inhibitory agent.

Career Highlights

John Hohmann is currently associated with Omeros Corporation, where he continues to advance his research and innovations. His work is characterized by a commitment to improving therapeutic options for patients with neurological conditions.

Collaborations

Hohmann has collaborated with esteemed colleagues, including George A Gaitanaris and John E Bergmann, to further enhance the impact of his research and inventions.

Conclusion

John Hohmann's contributions to the field of neurological treatments through his patents and collaborations highlight his dedication to innovation in medical science. His work continues to pave the way for new therapeutic approaches that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…